185 related articles for article (PubMed ID: 19440081)
1. A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive.
Glick ID; Bosch J; Casey DE
J Clin Psychopharmacol; 2009 Jun; 29(3):267-71. PubMed ID: 19440081
[TBL] [Abstract][Full Text] [Related]
2. Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials.
Goff DC; Keefe R; Citrome L; Davy K; Krystal JH; Large C; Thompson TR; Volavka J; Webster EL
J Clin Psychopharmacol; 2007 Dec; 27(6):582-9. PubMed ID: 18004124
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia.
Suzuki T; Uchida H; Takeuchi H; Nakajima S; Nomura K; Tanabe A; Yagi G; Watanabe K; Kashima H
Hum Psychopharmacol; 2009 Dec; 24(8):628-38. PubMed ID: 19946935
[TBL] [Abstract][Full Text] [Related]
4. The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.
Lerner V; Miodownik C; Gibel A; Sirota P; Bush I; Elliot H; Benatov R; Ritsner MS
J Clin Psychiatry; 2013 Dec; 74(12):1224-32. PubMed ID: 24434091
[TBL] [Abstract][Full Text] [Related]
5. Pregnenolone treatment reduces severity of negative symptoms in recent-onset schizophrenia: an 8-week, double-blind, randomized add-on two-center trial.
Ritsner MS; Bawakny H; Kreinin A
Psychiatry Clin Neurosci; 2014 Jun; 68(6):432-40. PubMed ID: 24548129
[TBL] [Abstract][Full Text] [Related]
6. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
Sachs GS; Ice KS; Chappell PB; Schwartz JH; Gurtovaya O; Vanderburg DG; Kasuba B
J Clin Psychiatry; 2011 Oct; 72(10):1413-22. PubMed ID: 21672493
[TBL] [Abstract][Full Text] [Related]
8. Memantine add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized, double-blind, placebo-controlled study.
Rezaei F; Mohammad-Karimi M; Seddighi S; Modabbernia A; Ashrafi M; Salehi B; Hammidi S; Motasami H; Hajiaghaee R; Tabrizi M; Akhondzadeh S
J Clin Psychopharmacol; 2013 Jun; 33(3):336-42. PubMed ID: 23609382
[TBL] [Abstract][Full Text] [Related]
9. Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia.
Kremer I; Vass A; Gorelik I; Bar G; Blanaru M; Javitt DC; Heresco-Levy U
Biol Psychiatry; 2004 Sep; 56(6):441-6. PubMed ID: 15364042
[TBL] [Abstract][Full Text] [Related]
10. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
11. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
Ventriglio A; Vincenti A; Centorrino F; Talamo A; Fitzmaurice G; Baldessarini RJ
Int Clin Psychopharmacol; 2011 Mar; 26(2):88-95. PubMed ID: 21030870
[TBL] [Abstract][Full Text] [Related]
12. Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study.
Wang Z; Gao K; Kemp DE; Chan PK; Serrano MB; Conroy C; Fang Y; Ganocy SJ; Findling RL; Calabrese JR
Psychopharmacol Bull; 2010; 43(4):5-21. PubMed ID: 21240149
[TBL] [Abstract][Full Text] [Related]
13. Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment.
Vayısoğlu S; Anıl Yağcıoğlu AE; Yağcıoğlu S; Karahan S; Karcı O; Gürel SC; Yazıcı MK
Schizophr Res; 2013 Jan; 143(1):207-14. PubMed ID: 23217729
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive-compulsive symptoms.
Poyurovsky M; Glick I; Koran LM
J Psychopharmacol; 2010 Jun; 24(6):861-6. PubMed ID: 19074541
[TBL] [Abstract][Full Text] [Related]
15. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
[TBL] [Abstract][Full Text] [Related]
16. Adjunct extended-release valproate semisodium in late life schizophrenia.
Sajatovic M; Coconcea N; Ignacio RV; Blow FC; Hays RW; Cassidy KA; Meyer WJ
Int J Geriatr Psychiatry; 2008 Feb; 23(2):142-7. PubMed ID: 17582828
[TBL] [Abstract][Full Text] [Related]
17. The selective glycine uptake inhibitor org 25935 as an adjunctive treatment to atypical antipsychotics in predominant persistent negative symptoms of schizophrenia: results from the GIANT trial.
Schoemaker JH; Jansen WT; Schipper J; Szegedi A
J Clin Psychopharmacol; 2014 Apr; 34(2):190-8. PubMed ID: 24525661
[TBL] [Abstract][Full Text] [Related]
18. Role of lamotrigine in the management of treatment-resistant bipolar II depression: a chart review.
Sharma V; Khan M; Corpse C
J Affect Disord; 2008 Nov; 111(1):100-5. PubMed ID: 18314200
[TBL] [Abstract][Full Text] [Related]
19. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.
Bowden CL; Vieta E; Ice KS; Schwartz JH; Wang PP; Versavel M
J Clin Psychiatry; 2010 Feb; 71(2):130-7. PubMed ID: 20122373
[TBL] [Abstract][Full Text] [Related]
20. [Are mood stabilizers beneficial in the treatment of schizophrenia?].
Berle JØ; Spigset O
Tidsskr Nor Laegeforen; 2005 Jun; 125(13):1809-12. PubMed ID: 16012547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
